Navigation Links
KaloBios Provides Update on KB001-A Partnership and Clinical Status
Date:7/28/2014

ctable="on">Pseudomonas aeruginosa (Pa) infection. KaloBios is conducting a 180 patient Phase 2 study in cystic fibrosis (CF) subjects with chronic Pa lung infection. KaloBios has received Orphan Drug designation from both the U.S. FDA and the European Medicines Agency for KB001-A for the treatment of Pa lung infection in CF patients. KB001-A has also received Fast Track Status from the U.S. FDA for the prevention of ventilator associated pneumonia. KaloBios is planning to seek a partner to help accelerate the development of this program.
  • KB004 is an anti-EphA3 mAb with potential in treating hematologic malignancies and solid tumors. KaloBios is running an ongoing Phase 1/2 study evaluating KB004 in hematologic malignancies. The Phase 1 dose escalation portion of that study in subjects with hematologic malignancies is ongoing. KaloBios initiated the Phase 2 expansion portion of the study focused on patients with certain EphA3 positive hematologic malignancies in early 2014.
  • KB003 is an anti-GM-CSF mAb with potential to treat inflammatory diseases that was being developed for the treatment of severe asthma. In early 2014, KaloBios completed a Phase 2 clinical study in 160 patients with severe asthma which did not meet its primary endpoint of improvement in FEV1 from baseline as compared to placebo. As a result, KaloBios discontinued development of this compound in severe asthma, and is continuing to analyze the Phase 2 data to review with thought leaders. KaloBios is currently evaluating other possible indications in order to determine next steps, if any, in the development of KB003.
  • All of the company's antibodies were generated using its proprietary Humaneered® technology, a method that converts nonhuman antibodies (typically mouse) into recombinant antibodies that have a high binding affinity to their target a
    '/>"/>

    SOURCE KaloBios Pharmaceuticals, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. KaloBios Pharmaceuticals Announces Pricing of Initial Public Offering
    2. KaloBios Pharmaceuticals Completes Initial Public Offering
    3. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma Data from KB002 Phase 1/2 Study Presented at the American Academy of Allergy, Asthma and Immunology Meeting
    4. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma
    5. Bioassociate Announces Initiation of Coverage on KaloBios Pharmaceuticals, Inc.
    6. KaloBios to Present at Future Leaders in the Biotech Industry Conference
    7. KaloBios Targeted Antibacterial KB001-A to be Featured in BIO 2013 Panel Discussion of "New Defenses Against Old Enemies"
    8. KaloBios to Present at Needham Healthcare Conference
    9. KaloBios Reports First Quarter 2013 Financial Results
    10. KaloBios to Present at Stifel Healthcare Conference 2013
    11. KaloBios KB001 Anti-Pseudomonas Antibody Study Published in Pediatric Pulmonology
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... Jan. 23, 2015  Now available for sale, The Armor1 ... that prevents ankle sprains by cushioning the ankle from ... securely around the outside of any shoe type and ... while still offering protection against sprains. With customers in ...
    (Date:1/23/2015)... Jan. 23, 2015 Cord Blood America, Inc. ( www.cordblood-america.com ... the "Company")  filed a Preliminary Proxy Statement, Schedule 14A, with ... and provides an update for shareholders detailing why a "YES" ... Dear Shareholders, As we reflect upon ...
    (Date:1/23/2015)... , Jan. 23, 2015  Mallinckrodt plc (NYSE: ... Directors has approved a share repurchase program. The open-ended ... million of Mallinckrodt plc ordinary shares. ... remain top priorities as we continue to pursue a ...
    Breaking Medicine Technology:The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
    ... VR Business Sales, Mergers & Acquisitions Charlotte, N.C. ... of Salisbury, NC.  This durable medical equipment provider specializes ... manual and power wheelchairs and scooters. "Penrod ... equipment providers I,ve seen.  The business generated a lot ...
    ... 2011 ,The " Global Diagnostic ... & Forecasts from 2010 to 2016 " analyzes and ... such as North America, Europe, Asia, and Rest of the ... in-depth TOC on Global Diagnostic Imaging (CT, MRI, X-Ray & ...
    Cached Medicine Technology:MarketsandMarkets: Global Diagnostic Imaging Market Estimated to Reach $26.6 Billion by 2016 2MarketsandMarkets: Global Diagnostic Imaging Market Estimated to Reach $26.6 Billion by 2016 3
    (Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce the release ... for kids with cancer. The Chemo Duck App, available on iTunes ... enjoyable games to help children of all ages living with cancer ... keep kids entertained, educated and at ease while waiting for clinic ...
    (Date:1/22/2015)... EAGAN, Minn. (PRWEB) January 22, 2015 Blue ... discover those Minnesotans who exemplify what it means to “Live ... a chance for people to share their stories about how ... adversity or simply inspired others by living in the moment. ...
    (Date:1/22/2015)... (PRWEB) January 22, 2015 Thousand of ... Medical Care recalled its GranuFlo and NaturaLyte dialysis concentrates ... underway in U.S. District Court, District of Massachusetts, Bernstein ... 20th, the Court has remanded a case filed by ...
    (Date:1/22/2015)... 22, 2015 A study recently ... flagship journal Medicine & Science in Sports & ... may help reduce gastrointestinal (GI) problems associated with ... Participants in the double-blind, placebo-controlled study took 10 ...
    (Date:1/22/2015)... Payday lending practices in four southern states worsen ... to the states that permit them, according to a ... Race and Wealth. , While they generate hundreds of ... the same time substantially depress economic activity, according to ...
    Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
    ... dismissed by health officials, following the negative results from analysis// ... H5N1 virus. ,Officials belonging to the health department ... outbreak of bird flu has been reported so far, based ... country. ,All necessary precautionary measures have been taken ...
    ... March 2006 online issue of BMC Public Health focuses on ... in Vietnam and the incidence of prostate cancer (CaP).// This ... linked to CaP. ,However by Dr. Leavy and ... two. Between 2001 and 2002, 606 men with CaP from ...
    ... their concern over the apparent increase in preterm births ... in February. // ,The study found that preterm ... The study found that even among low risk women aged ... ,The study also showed that assisted conceptions, multiple pregnancies, ...
    ... study published in the New Zealand Medical Journal says ... middle-aged adults are increasing at an alarming rate. // ... the Heart Foundation and colleagues, shows that the death ... especially in Maori and lower-socioeconomic groups. ,Heart disease ...
    ... Churchill and Ernest Hemingway. We are talking about the Panama ... woven from palm fibres, considered a status symbol for men ... Panama hats are in worldwide demand and numerous German milliners ... ,"These days when people want to treat themselves to ...
    ... biological weapons is not isolated it has been categorized in ... to spread, kill effectively and call for special actions by ... hope by Vince Fischetti’s laboratory at Rockefeller University which suggests ... anthrax infections and even decontaminate areas in which anthrax spores ...
    Cached Medicine News:Health News:Rising Number of Preterm Births Cause Concern 2Health News:Panama hat making a slow comeback 2
    ... The innovative PoleStar N20, exclusively distributed ... intra-operative MRI. Combining intra-operative imaging ... registration-free system, PoleStar N20 is one ... available today. , , Exceptional image ...
    ... II™ single use automatic clip ... clips., ,The Auto Suture™ ... application in many types of ... and other tubular structures and ...
    ... The Auto Suture™ Powered LDS™ single use ... tissue within the cartridge jaw and a ... two closed staples. , ,The Auto ... titanium staples have application in abdominal, gynecological, ...
    ... The LIGACLIP Clip Applier is a ... metallic ligating clips. This instrument is used ... produced from either 316L stainless steel or ... ligation of tubular structures where a nonabsorbable ...
    Medicine Products: